12 search results for the keyword shortage notice in latest news

News

Shortage Notice: Nardil (phenelzine sulfate) 15mg tablets

Kyowa Kirin, the sole manufacturers of Nardil (phenelzine sulfate) 15mg tablets, are currently experiencing temporary disruptions. Kyowa Kirin, the main supplier of Nardil (phenelzine sulfate) 15mg tablets have advised a delayed resupply date of March 2020. Supplies are available from...

News

Shortage Notice: Mianserin 10mg and 30mg tablets

Mylan,  the sole manufacturers of Mianserin 10mg and 30mg tablets, are currently experiencing temporary supply disruptions. Mylan,  the sole manufacturers of Mianserin 10mg and 30mg tablets have advised a resupply date of end of 2019 Supplies are available from specialist...

News

Shortage Notice: Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets

Teva,  the sole manufacturers of Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets, are currently experiencing temporary supply disruptions. Teva,  the sole manufacturers of Tiagabine (Gabitril) 5mg, 10mg and 15mg tablets have advised a resupply date of end of October 2019...

News

Health & Care Review

Keeping up with all the latest developments in health and care policy could almost be a full time job and PSNC regularly receives questions from LPCs and pharmacy contractors about what is going on in the wider health and care...

News

Shortage Notice: Fluoxetine 10mg, 30mg and 40mg capsules

Morningside and Advanz, the manufacturers of Fluoxetine 10mg, 30mg and 40mg capsules, are currently experiencing temporary disruptions. Please see a table below which summarises the overall fluoxetine availability: Supplies are available from specialist importers on an ‘unlicensed’ basis. Ensure that...

News

Contractor Notice: SSP Endorsement Errors

Following the announcement of the first Serious Shortage Protocols (SSPs) issued on 3rd October 2019 for Fluoxetine capsules, PSNC has been working with NHS Business Services Authority (NHSBSA) to understand if claims are being submitted in accordance with SSP endorsement...